$DNA News

What Ginkgo Bioworks Bears Saw Before The Fall

Ginkgo Bioworks Holdings Consensus Price Target Raised 14.29% to $8.16

Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand

TD Cowen Maintains Hold on Ginkgo Bioworks Holdings, Raises Price Target to $11

What's Going on With Ginkgo Bioworks Stock on Friday?

Ginkgo Bioworks To Provide Autonomous Lab Access To NSF X-Labs Researchers, Contributing Cloud Lab Time And Protein Testing Services To $1.5B Science Program; To Provide Cloud Lab Time And Remote Access For NSF X-Labs Teams; To Offer Protein Testing Services To NSF X-Labs Teams

Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop

Ginkgo Bioworks To Integrate Araceli Biosciences' Endeavor High-Content Imaging Instrument Into Nebula, The Company's Autonomous Lab

Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know

Ginkgo Bioworks: The Valuation Has Outrun The Business

This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled

Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?

Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts

Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data

Ginkgo Bioworks Holdings Consensus Price Target Cut by 22.22% to $7.14

Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines

BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target

Ginkgo Bioworks: Another Pivot, Still No Proof Of Product-Market Fit

TD Cowen Downgrades Ginkgo Bioworks Holdings (DNA)